纳米晶体给药系统用于药物输送的研究进展
作者：胡蝶;胡一桥;孟政杰;
Author：
收稿日期： 年卷（期）页码：2014,29(01):-87-90
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：纳米晶体;制备技术;药物递送;生物利用度;给药系统
Key words：
基金项目：
中文摘要
纳米晶体作为一种新型载药系统,可有效提高药物的溶解性及生物利用度,可用于多种递药系统,已成为药剂学研究的新热点。通过查阅相关文献,对纳米晶体技术的制备工艺、表征及其在各种药物递送方面的应用进行了综述。
参考文献
[1]Sant S,Tao SL,Fisher O,et al.Microfabrication technologies for oral drug delivery[J].Adv Drug Deliv Rev,2012,64(6):496-507.
[2]Krishnaiah YSR.Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs[J].J Bioequiv Availab,2010,2(2):28-36.
[3]Carrier RL,Miller LA,Ahmed I.The utility of cyclodextrins for enhancing oral bioavailability[J].J Control Rel,2007,123(2):78-99.
[4]Rautio J,Kumpulainen H,Heimbach T,et al.Prodrugs:Design and clinical applications[J].Nat Rev Drug Dis,2008,7(3):255-270.
[5]Shegokar R,Muller RH.Nanocrystals:Industrially feasible multifunctional formulation technology for poorly soluble actives[J].Int J Pharm,2010,399(1-2):129-139.
[6]Moschwitzer JP.Drug nanocrystals in the commercial pharmaceutical development process[J].Int J Pharm,2012,453(3):142-156.
[7]Chan HK,Kwok PCL.Production methods for nanodrug particles using the bottom-up approach[J].Adv Drug Deliv Rev,2011,63(6):406-416.
[8]Sharma P,Garg S.Pure drug and polymer based nanotechnologies for the improved solubility,stability,bioavailability and targeting of anti-HIV drugs[J].Adv Drug Deliv Rev,2010,62(4-5):491-502.
[9]Kesisoglou F,Panmai S,Wu Y.Nanosizing-oral formulation development and biopharmaceutical evaluation[J].Adv Drug Deliv Rev,2007,59(7):631-644.
[10]Merisko-Liversidge EM,Liversidge GG.Drug nanoparticles:Formulating poorly water-soluble compounds[J].Toxicol Pathol,2008,36(1):43-48.
[11]Tanaka Y,Inkyo M,Yumoto R,et al.Nanoparticulation of probucol,a poorly water-soluble drug,using a novel wet-milling process to improve in vitro dissolution and in vivo oral absorption[J].Drug Dev Ind Pharm,2012,38(8):1015-1023.
[12]Chen H,Khemtong C,Yang X,et al.Nanonization strategies for poorly water-soluble drugs[J].Drug Discov Today,2011,16(7-8):354-360.
[13]Gao L,Zhang D,Chen M.Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system[J].J Nanoparticle Res,2008,10(5):845-862.
[14]Merisko-Liversidge E,Liversidge GG.Nanosizing for oral and parenteral drug delivery:A perspective on formulating poorlywater soluble compounds using wet media milling technology[J].Adv Drug Deliv Rev,2011,63(6):427-440.
[15]Junghanns J,Muller RH.Nanocrystal technology,drug delivery and clinical applications[J].Int J Nanomed,2008,3(3):295-309.
[16]Hao L,Wang X,Zhang D,et al.Studies on the preparation,characterization and pharmacokinetics of Amoitone B nanocrystals[J].Int J Pharm,2012,433(1-2):157-164.
[17]Keck CM,Muller RH.Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation[J].Eur J Pharm Biopham,2006,62(1):3-16.
[18]Xu Y,Liu X,Lian R,et al.Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization[J].Int J Pharm,2012,438(1-2):287-295.
[19]Wang L,Hao Y,Liu N,et al.Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method[J].Drug Dev Ind Pharm,2012(00):1-9.
[20]Adhiyaman R,Basu S K.Crystal modification of dipyridamole using different solvents and crystallization conditions[J].Int J Pharm,2006,321(1-2):27-34.
[21]Hu J,Ng WK,Dong Y,et al.Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying[J].Int J Pharm,2011,404(1-2):198-204.
[22]Chan HK,Kwok PC.Production methods for nanodrug particles using the bottom-up approach[J].Adv Drug Deliv Rev,2011,63(6):406-416.
[23]Zhao H,Wang J,Zhang H,et al.Facile preparation of danazol nanoparticles by high-gravity anti-solvent precipitation method[J].Chin J Chem Eng,2009,17(2):318-323.
[24]Hu TT,Wang JX,Shen ZG,et al.Engineering of drug nanoparticles by HGCP for pharmaceutical applications[J].Particuology,2008,6(4):239-251.
[25]Knutson BL,Debenedetti PG,Tom JW.Preparation of microparticulates using supercritical fluids[J].Drugs Pharm S,1996,77:89-126.
[26]Sheth P,Sandhu H,Singhal D,et al.Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production[J].Curr Drug Deliv,2012,9(3):269-284.
[27]Byrappa K,Ohara S,Adschiri T.Nanoparticles synthesis using supercritical fluid technology-towards biomedical applications[J].Adv Drug Deliv Rev,2008,60(3):299-327.
[28]Kunastitchai S,Pichert L,Sarisuta N,et al.Application of aerosol solvent extraction system(ASES)process for preparation of liposomes in a dry and reconstitutable form[J].Int J Pharma,2006,316(1-2):93-101.
[29]Tozuka Y,Miyazaki Y,Takeuchi H.A combinational supercritical CO2system for nanoparticle preparation of indomethacin[J].Int J Pharma,2010,386(1-2):243-248.
[30]Kim MS,Kim JS,Park HJ,et al.Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process[J].Int J Nanomed,2011,6:2997-3009.
[31]Gao L,Zhang D,Chen M.Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system[J].J Nanopart Res,2008,10(5):845-862.
[32]Lai F,Pini E,Angioni G,et al.Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets[J].Eur J Pharm Biopharm,2011,79(3):552-558.
[33]Rawat N,Kumar MS,Mahadevan N.Solubility:Particle size reduction is a promising approach to improve the bioavailability of lipophillic drugs[J].Int J Recent Adv in Pharma Res,2011,1:8-18.
[34]Quan P,Xia D,Piao H,et al.Nitrendipine nanocrystals:Its preparation,characterization,and in vitro-in vivo evaluation[J].AAPS Pharm Sci Tech,2011,12(4):1136-1143.
[35]Jinno J,Kamada N,Miyake M,et al.Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug,cilostazol,in beagle dogs[J].J Control Rel,2006,111(1):56-64.
[36]Bansal S,Bansal M,Kumria R.Nanocrystals:Current strategies and trends[J].Technology,2012,4:10.
[37]Merisko-Liversidge E,Liversidge GG,Cooper ER.Nanosizing:A formulation approach for poorly-water-soluble compounds[J].Eur J Pharma S,2003,18(2):113-120.
[38]Zhang H,Hollis CP,Zhang Q,et al.Preparation and antitumor study of camptothecin nanocrystals[J].Int J Pharm,2011,415(1-2):293-300.
[39]Chiou H,Li L,Hu T,et al.Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation[J].Int J Pharm,2007,331(1):93-98.
【关闭】
